CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1177-1181

  Soiffer, R J ^a,b   Freedman, A S ^a   Neuberg, D ^a   Fisher, D C ^a   Alyea, E P ^a   Gribben, J ^a   Schlossman, R L ^a   Bartlett Pandite, L ^a   Kuhlman, C ^a   Murray, C ^a   Freeman, A ^a   Mauch, P ^a   Anderson, K C ^a   Nadler, L M ^a   Ritz, J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Allogeneic BMT; Lymphoma; T cell depletion

Indexed keywords

ANTINEOPLASTIC AGENT; CD6 ANTIGEN; COMPLEMENT; MONOCLONAL ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HUMAN; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0031852301     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701271     Document Type: Article

References (28)

1. Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New Engl J Med 1987; 316; 1493-1500.
2. Vose JM, Armitage JO, Kessinger A et al. High-dose chemotherapy and autologous transplant with peripheral blood stem cells. Oncology 1993; 7: 23-29.
3. Freedman AS, Takvorian T, Anderson KC et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma. Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990; 8: 784-792.
4. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl J Med 1995; 333: 1540-1547.
5. Appelbaum FR, Sullivan KM, Buckner CD et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation. J Clin Oncol 1987; 5: 1340-1347.
6. Shepherd JD, Barnett MJ, Connors JM et al. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. Bone Marrow Transplant 1993; 12: 591-596.
7. Jones RJ, Ambinder RF, Piantadosi S et al. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649-653.
8. Chopra R, Goldstone AH, Pearce R et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 1992; 10: 1690-1695.
9. Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050-1055.
10. Stone RM, Neuberg D, Soiffer RJ et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2534-2541.
11. Darrington DL, Vose JM, Anderson JR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high dose chemotherapy and autologous stem-cell transplant for lymphoid malignancies. J Clin Oncol 1994; 12: 2528-2534.
12. Soiffer RJ, Murray C, Mauch P et al. Prevention of graft-versus-host disease by selective depletion of CD6 positive T lymphocytes from donor bone marrow. J Clin Oncol 1992; 10: 1191-2000.
13. Soiffer RJ, Fairclough D, Robertson M et al. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood 1997; 89: 3039-3047.
14. Rohatiner A, Gelber R, Schlossman SF et al. Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. Transplantation 1986; 42: 73-80.
15. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of HLA matched sibling donors. Transplantation 1974; 18: 295-302.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc 1958; 53: 457-464.
17. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J Roy Star Soc A 1972; 135: 185-206.
18. Cox DR, Oakes D. The Analysis of Survival Data. Chapman Hall: London, 1984.
19. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
20. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
21. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
22. Kolb HJ, Mittermuller J, Clem C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
23. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
24. Soiffer RJ, Murray C, Gonin R, Ritz J. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood 1994; 84: 964-971.
25. Vey N, Blaise D, Tiberghien P, Anal M. A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas. Leuk Lymphoma 1996; 21: 107-114.
26. Van Besien KW, Mehra RC, Giralt SA et al. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology. Am J Med 1996; 100: 299-305.
27. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
28. Sweetenham JW, Liberti G, Pearce R et al. High-dose chemotherapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma. J Clin Oncol 1996; 12: 1358-1365.